Reply to 'Staging for distant metastases in operable breast cancer: A suggested expansion of the ESMO guideline recommendation for staging imaging of node-negative, hormonal receptor-negative disease' by U. Gueth et al

摘要

Dr Giith et al. report an analysis of postoperative staging of patients with breast cancer in the University of Basel cohort. Their main message is that their patients with ER-negative apparent stage I breast cancer have a similar probability of distant metastases as patients with apparent stage II disease. Based on their data, it would seem logical to apply the same protocols of staging to patients with 'high-risk stage I' breast cancer.